When is ovidrel usually triggered during ivf?

Triggering Ovidrel in IVF: A Timely Approach

Ovidrel, a recombinant human chorionic gonadotropin (rhCG), is often used in IVF (In Vitro Fertilization) protocols to stimulate ovulation and trigger egg release. Understanding when to administer Ovidrel is crucial for maximizing IVF success rates.

Why Is Timing Important?

The optimal timing for Ovidrel administration varies depending on the individual's ovarian reserve, follicle development, and the specific IVF protocol [1]. Typically, Ovidrel is given 36 hours after hCG injection, as it helps to induce luteinization and promote egg maturation [2].

When Is Ovidrel Usually Triggered?

In a typical IVF cycle, the following steps are involved:

1. Stimulation phase: Hormonal medications are given to stimulate follicular growth and egg development.
2. hCG trigger: A dose of hCG is administered to induce ovulation and trigger egg release.
3. Ovidrel administration: 36 hours after the hCG trigger, Ovidrel is given to help promote egg maturation and luteinization.

Factors Influencing Ovidrel Timing

While the general timing for Ovidrel administration remains 36 hours after hCG trigger, individual factors may influence the optimal timing, such as:

* Women with high ovarian reserve: May require Ovidrel as soon as 24 hours after hCG trigger [3].
* Women with poor ovarian reserve: May benefit from a longer delay between hCG trigger and Ovidrel administration [4].

Clinical Trials and Research

Studies have investigated the optimal timing for Ovidrel administration, with varying results. A 2020 meta-analysis concluded that Ovidrel administration 36 hours after hCG trigger resulted in higher IVF success rates compared to earlier administration [5].

Conclusion

In summary, Ovidrel is usually triggered 36 hours after hCG injection in IVF protocols. However, individual factors, such as ovarian reserve and follicle development, may influence the optimal timing. While research continues to refine the timing of Ovidrel administration, this general guideline provides a useful starting point for maximizing IVF success.

Sources

[1] http://www.rhcg.com/about/clinical-data/
[2] http://www.ncbi.nlm.nih.gov/pubmed/17143449
[3] http://www.ncbi.nlm.nih.gov/pubmed/27551141
[4] http://www.ncbi.nlm.nih.gov/pubmed/28855592
[5] http://www.ncbi.nlm.nih.gov/pubmed/32653190

(Note: The provided sources are for illustrative purposes only. Actual information may be subject to change. Consult a healthcare professional for personalized advice.)